Hypertension as a risk factor for atherosclerosis: Cardiovascular risk assessment

被引:66
|
作者
Poznyak, Anastasia V. [1 ]
Sadykhov, Nikolay K. [2 ]
Kartuesov, Andrey G. [3 ]
Borisov, Evgeny E. [2 ]
Melnichenko, Alexandra A. [3 ]
Grechko, Andrey V. [4 ]
Orekhov, Alexander N. [1 ,2 ,3 ]
机构
[1] Inst Atherosclerosis Res, Moscow, Russia
[2] Petrovsky Natl Res Ctr Surg, Moscow, Russia
[3] Inst Gen Pathol & Pathophysiol, Lab Angiopathol, Moscow, Russia
[4] Fed Res & Clin Ctr Intens Care Med & Rehabilitol, Moscow, Russia
来源
FRONTIERS IN CARDIOVASCULAR MEDICINE | 2022年 / 9卷
基金
俄罗斯科学基金会;
关键词
atherosclerosis; hypertension; cardiovascular disease; cardiovascular risk; vessels; BLOOD-PRESSURE; DISEASE RISK; EPIDEMIOLOGY; CHOLESTEROL; SOCIETY; BURDEN;
D O I
10.3389/fcvm.2022.959285
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Atherosclerosis is a predecessor of numerous cardiovascular diseases (CVD), which often lead to morbidity and mortality. Despite the knowledge of the pathogenesis of atherosclerosis, an essential gap in our understanding is the exact trigger mechanism. A wide range of risk factors have been discovered; however, a majority of them are too general to clarify the launching mechanism of atherogenesis. Some risk factors are permanent (age, gender, genetic heritage) and others can be modified [tobacco smoking, physical inactivity, poor nutrition, high blood pressure, type 2 diabetes (T2D), dyslipidemia, and obesity]. All of them have to be taken into account. In the scope of this review, our attention is focused on hypertension, which is considered the most widespread among all modifiable risk factors for atherosclerosis development. Moreover, high blood pressure is the most investigated risk factor. The purpose of this review is to summarize the data on hypertension as a risk factor for atherosclerosis development and the risk assessment.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Degree Of Risk Factor Control And Incident Cardiovascular Diseases In Patients With Hypertension
    Kou, Minghao
    Wang, Xuan
    Ma, Hao
    Li, Xiang
    Heianza, Yoriko
    Qi, Lu
    HYPERTENSION, 2022, 79
  • [42] Advantages of new cardiovascular risk-assessment strategies in high-risk patients with hypertension
    Ruilope, LM
    Segura, J
    CLINICAL THERAPEUTICS, 2005, 27 (10) : 1658 - 1668
  • [43] Uric acid as a cardiovascular risk factor in arterial hypertension
    Puig, JG
    Ruilope, LM
    JOURNAL OF HYPERTENSION, 1999, 17 (07) : 869 - 872
  • [44] Hypertension as a cardiovascular risk factor in autoimmune rheumatic diseases
    Bartoloni, Elena
    Alunno, Alessia
    Gerli, Roberto
    NATURE REVIEWS CARDIOLOGY, 2018, 15 (01) : 33 - 44
  • [45] Measurement of subclinical atherosclerosis: beyond risk factor assessment
    Bisoendial, RJ
    Hovingh, GK
    de Groot, E
    Kastelein, JJP
    Lansberg, PJ
    Stroes, ESG
    CURRENT OPINION IN LIPIDOLOGY, 2002, 13 (06) : 595 - 603
  • [46] Risk-factor clustering and cardiovascular disease risk in hypertensive patients
    Weycker, Derek
    Nichols, Gregory A.
    O'Keeffe-Rosetti, Maureen
    Edelsberg, John
    Khan, Zeba M.
    Kaura, Satyin
    Oster, Gerry
    AMERICAN JOURNAL OF HYPERTENSION, 2007, 20 (06) : 599 - 607
  • [47] Menopause as a cardiovascular risk factor: therapeutic implications of hypertension
    Posadzy-Malaczynska, Anna
    MENOPAUSE REVIEW-PRZEGLAD MENOPAUZALNY, 2011, 10 (01): : 40 - 44
  • [48] Prolactin and Preclinical Atherosclerosis in Menopausal Women With Cardiovascular Risk Factors
    Georgiopoulos, George A.
    Stamatelopoulos, Kimon S.
    Lambrinoudaki, Irene
    Lykka, Maria
    Kyrkou, Katerina
    Rizos, Dimitrios
    Creatsa, Maria
    Christodoulakos, George
    Alevizaki, Maria
    Sfikakis, Petros P.
    Papamichael, Christos
    HYPERTENSION, 2009, 54 (01) : 98 - 105
  • [49] Multisite Atherosclerosis and Cardiovascular Event Risk: The Multiethnic Study of Atherosclerosis
    Wong, Nathan D.
    Luo, Yanting
    Allison, Matthew
    Budoff, Matthew
    Nasir, Khurram
    Blumenthal, Roger
    Burke, Gregory
    O'Leary, Daniel
    Criqui, Michael
    CIRCULATION, 2012, 126 (21)
  • [50] Assessment of Lifetime Risk for Cardiovascular Disease: Time to Move Forward
    Sigala, Evangelia G.
    Panagiotakos, Demosthenes B.
    CURRENT CARDIOLOGY REVIEWS, 2024, 20 (06) : 18 - 33